<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575236</url>
  </required_header>
  <id_info>
    <org_study_id>Schulthess_Anä_3</org_study_id>
    <secondary_id>Schulthess_Anä_3</secondary_id>
    <nct_id>NCT01575236</nct_id>
  </id_info>
  <brief_title>A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway</brief_title>
  <official_title>A Randomized Non Crossover Study of the GuardianTM Versus SupremeTM Laryngeal Mask Airway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schulthess Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Schulthess Klinik</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure,
      fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the
      LMA SupremeTM in paralyzed, anesthetized patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The GuardianTM is a new extraglottic airway device which brings together features of both the
      LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation,
      airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use -
      prevention of disease transmission). In the following randomized, non-crossover study, the
      investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure,
      fiberoptic position and ease of gastric tube placement differ between the GuardianTM and the
      LMA SupremeTM in paralyzed, anesthetized patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy of oropharyngeal seal pressure</measure>
    <time_frame>5 min</time_frame>
    <description>this will be measured over the full range of cuff volumes (0-40 ml) and at an intracuff pressure of 60 cm H2O</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>anatomic position</measure>
    <time_frame>5 min</time_frame>
    <description>this will be determined fiberoptically via the airway tube over the full range of cuff volumes and at an intracuff pressure of 60 cm H2O</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Adverse Anesthesia Outcome</condition>
  <arm_group>
    <arm_group_label>Guardian</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Guardian Laryngeal Mask</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supreme</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supreme Laryngeal Mask Airway</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Guardian Laryngeal Mask</intervention_name>
    <description>ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion</description>
    <arm_group_label>Guardian</arm_group_label>
    <other_name>Guardian Laryngeal Mask, Umedaes</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Supreme Laryngeal Mask Airway</intervention_name>
    <description>ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric insertion</description>
    <arm_group_label>Supreme</arm_group_label>
    <other_name>Supreme Laryngeal Mask Airway, LMA Deutschland GmbH</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1 or 2

          -  Age 18-75 yr

          -  Written informed consent

        Exclusion Criteria:

          -  Difficult airway

          -  Non fasted

          -  BMI &gt; 35
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Keller, MD MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Anästhesie Schulthess Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinik für Anästhesie</name>
      <address>
        <city>Innsbruck</city>
        <state>Tirol</state>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2012</study_first_submitted>
  <study_first_submitted_qc>April 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>August 6, 2012</last_update_submitted>
  <last_update_submitted_qc>August 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Schulthess Klinik</investigator_affiliation>
    <investigator_full_name>ChristianKeller</investigator_full_name>
    <investigator_title>MD, M.Sc.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

